Methotrexate Pfizer

Methotrexate, the active ingredient in Methotrexate Pfizer, is an antimetabolite presented as an oral formulation for systemic use. It is employed to manage rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia, osteosarcoma, and gestational trophoblastic disease in appropriate patient populations. It is typically prescribed by rheumatologists, dermatologists, and oncologists effectively.

GNH USA supplies Methotrexate Pfizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams across Europe, Asia and the Americas worldwide, ensuring timely delivery and regulatory compliance.

Methotrexate is an antimetabolite used in several disease categories, primarily autoimmune disorders and certain malignancies. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: decreases skin lesion severity and plaque formation. - Acute lymphoblastic leukemia: interferes with malignant cell proliferation to achieve remission. - Osteosarcoma: inhibits tumor growth as part of combination chemotherapy. - Gestational trophoblastic disease: promotes resolution of trophoblastic tissue.

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting - Fatigue or weakness - Mouth sores (stomatitis) - Mild elevation of liver enzymes - Low white blood cell count (leukopenia)

Serious or Rare Side Effects: - Severe liver toxicity or fibrosis - Pulmonary fibrosis or interstitial pneumonitis - Life‑threatening infection due to bone‑marrow suppression

Before initiating methotrexate therapy, several safety considerations should be observed. - Liver monitoring: perform baseline and periodic liver function tests. - Hematologic monitoring: check complete blood count regularly. - Pregnancy avoidance: contraindicated in pregnancy; effective contraception required. - Renal function: adjust dose or avoid use in significant renal impairment. - Concomitant drugs: review use of NSAIDs and other hepatotoxic agents. - Store at below 25°C: keep in the original container, protect from moisture and light.

Methotrexate interacts with several medicines that can alter its efficacy or toxicity.

Major Interactions (Avoid): - High‑dose NSAIDs: increase risk of renal toxicity. - Penicillins (e.g., ampicillin): may reduce methotrexate clearance. - Live vaccines: heightened risk of severe infection.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may increase methotrexate plasma levels. - Warfarin: enhanced anticoagulant effect requiring INR monitoring.